Risk of Pancreatic Cancer and Use of Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes: A Propensity Score-Matching Analysis.

Endocrinol Metab (Seoul) · 2023 · PMC10475964 · PMID 37469033

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The authors pointed out that the possibility of reverse causality could not be ruled out, considering the absence of an increasing trend of pancreatic cancer with exposure duration, and limited follow-up (mean duration of follow-up, 3.6 years).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.